5-methoxyflavone, a flavonoid analog, is a novel DNA polymerase-ß inhibitor and neuroprotective agent against ß-amyloid toxicity. 5-Methoxyflavone was confirmed to be an inhibitor of DNA pol-β activity using cultured primary neurons, a valuable model for examining the neuroprotective effects of putative DNA pol-β inhibitors because treatment with Aβ causes DNA replication and cell death in these neurons. 5-methoxyflavone decreased the number of S-phase neurons and the subsequent apoptotic death induced by Aβ, which is consistent with the inhibition of DNA pol-β. 5-Methoxyflavone is the first flavonoid compound that, as opposed to having broad antioxidant and anti-inflammatory effects, is able to stop neurodegeneration through a specific molecular mechanism.
Physicochemical Properties
Molecular Formula | C16H12O3 | |
Molecular Weight | 252.26 | |
Exact Mass | 252.079 | |
CAS # | 42079-78-7 | |
Related CAS # |
|
|
PubChem CID | 94525 | |
Appearance | Yellow solid powder | |
Density | 1.24g/cm3 | |
Boiling Point | 422.5ºC at 760mmHg | |
Melting Point | 131-133°C | |
Flash Point | 201.1ºC | |
Index of Refraction | 1.548 | |
LogP | 3.468 | |
Hydrogen Bond Donor Count | 0 | |
Hydrogen Bond Acceptor Count | 3 | |
Rotatable Bond Count | 2 | |
Heavy Atom Count | 19 | |
Complexity | 368 | |
Defined Atom Stereocenter Count | 0 | |
SMILES | O1C(=C([H])C(C2C(=C([H])C([H])=C([H])C1=2)OC([H])([H])[H])=O)C1C([H])=C([H])C([H])=C([H])C=1[H] |
|
InChi Key | XRQSPUXANRGDAV-UHFFFAOYSA-N | |
InChi Code | InChI=1S/C16H12O3/c1-18-13-8-5-9-14-16(13)12(17)10-15(19-14)11-6-3-2-4-7-11/h2-10H,1H3 | |
Chemical Name | 5-methoxy-2-phenylchromen-4-one | |
Synonyms | 5-Methoxyflavone | |
HS Tariff Code | 2934.99.9001 | |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
Targets | DNA polymerase β | ||
ln Vitro |
|
||
ln Vivo | 5-Methoxyflavone (100, 150 mg/kg, i.p) dramatically reduces the amount of time it takes to lose the righting reflex. 5. A notable and dose-dependent decrease in spontaneous locomotor activity is shown by methylflavone (50, 100, and 150 mg/kg, i.p.). 5. The rearing response is decreased by methylflavone (50, 100 mg/kg, i.p.). 5-The grooming response was totally eliminated by methylflavone (100, 125, and 150 mg/kg, i.p. ), just like in animals treated with diazepam[3]. | ||
Enzyme Assay |
Human DNA Pol-β Assay [1] DNA pol-β inhibition was evaluated with a specific DNA pol-β assay kit. The assay was carried out strictly following the manufacturer’s instructions. Briefly, a reaction mixture containing a gapped DNA template, dNTPs (both supplied with the kit), and DNA pol-β was incubated for 30 min at RT with or without the compound to be tested. The formation of repaired duplexes, which, unlike gapped DNA, selectively incorporate a fluorescent dye in the presence of Reagent U (both supplied by the kit) was determined by measuring at 535 nm with the excitation wavelength at 485 nm in a fluorimeter. OA (50 μM) was used as a positive control for inhibition. Activity was evaluated as fluorescent signal to no-enzyme-background ratio. |
||
Cell Assay | The MTT assay is used to assess the cell viability after treating MOLT-4, U937, or PBMC cells with DMF, TMF, PMF, 5-MF, or 2'-MF at different concentrations for 24 hours. | ||
Animal Protocol |
|
||
References |
[1]. Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity. J Nat Prod. 2015 Nov 25;78(11):2704-11. [2]. Sedative-hypnotic like effect of 5-methoxyflavone in mice and investigation on possible mechanisms by in vivo and in silico methods. Biomed Pharmacother. 2018 Dec;108:85-94. [3]. Methoxyflavone derivatives modulate the effect of TRAIL-induced apoptosis in human leukemic cell lines. J Hematol Oncol. 2011 Dec 21;4:52. |
||
Additional Infomation | 5-Methoxyflavone is an ether and a member of flavonoids. |
Solubility Data
Solubility (In Vitro) | DMSO: 50~125 mg/mL (198.2~495.5 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (8.25 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (8.25 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (8.25 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.9642 mL | 19.8208 mL | 39.6416 mL | |
5 mM | 0.7928 mL | 3.9642 mL | 7.9283 mL | |
10 mM | 0.3964 mL | 1.9821 mL | 3.9642 mL |